title: Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.
authors.affiliation: University of Calgary, Calgary, Canada.
authors.forename: Remo
authors.initials: R
authors.lastname: Panaccione
authors.forename: Richard N
authors.initials: RN
authors.lastname: Fedorak
authors.forename: Guy
authors.initials: G
authors.lastname: Aumais
authors.forename: Charles N
authors.initials: CN
authors.lastname: Bernstein
authors.forename: Alain
authors.initials: A
authors.lastname: Bitton
authors.forename: Ken
authors.initials: K
authors.lastname: Croitoru
authors.forename: Robert
authors.initials: R
authors.lastname: Enns
authors.forename: Brian
authors.initials: B
authors.lastname: Feagan
authors.forename: Marty
authors.initials: M
authors.lastname: Fishman
authors.forename: Gordon
authors.initials: G
authors.lastname: Greenberg
authors.forename: Anne
authors.initials: A
authors.lastname: Griffiths
authors.forename: John K
authors.initials: JK
authors.lastname: Marshall
authors.forename: Imran
authors.initials: I
authors.lastname: Rasul
authors.forename: Daniel
authors.initials: D
authors.lastname: Sadowski
authors.forename: Ernest
authors.initials: E
authors.lastname: Seidman
authors.forename: Hillary
authors.initials: H
authors.lastname: Steinhart
authors.forename: Lloyd
authors.initials: L
authors.lastname: Sutherland
authors.forename: Eric
authors.initials: E
authors.lastname: Walli
authors.forename: Gary
authors.initials: G
authors.lastname: Wild
authors.forename: C Noel
authors.initials: CN
authors.lastname: Williams
authors.forename: Mary
authors.initials: M
authors.lastname: Zachos
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D000075202:Contraindications; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab